Zhijin Zhang – Trademark Portfolio
Entity Type: 01
Zhijin Zhang owns a portfolio of 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as VIVOK, ZEROCEAN, DOCTOROSE, FEATURESEA, and DARSON-SMART. Of these, 5 are registered and 1 is pending. The portfolio spans 5 Nice Classification classes, led by Class 3 (Cosmetics & Cleaning) and Class 20 (Furniture). Headquartered in Ji 'an.
Furong Town, Wan 'an County
No. 1, Keyuan Community
Ji 'an 343800 , CN
Showing of trademarks Trademarks
Trademark Classifications
Zhijin Zhang's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Carpets, rugs, mats and matting, linoleum and other materials for covering floors
Frequently Asked Questions
How many trademarks does Zhijin Zhang have?
Zhijin Zhang has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 pending, 1 abandoned.
What trademark classes does Zhijin Zhang file in?
Zhijin Zhang files trademarks across 5 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 20 (Furniture), Class 9 (Computers & Electronics), Class 27 (Floor Coverings), Class 10 (Medical Apparatus). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Zhijin Zhang's most well-known trademarks?
Zhijin Zhang's registered trademark portfolio includes well-known marks such as VIVOK, ZEROCEAN, DOCTOROSE, FEATURESEA, and DARSON-SMART. These are among 5 currently registered trademarks in the portfolio.
What is Zhijin Zhang's trademark registration success rate?
Zhijin Zhang has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 1 application is pending review.